Brainsway Deep TMS Therapy - for Brain Disorder Treatment

Need Help with Your OCD?

Are Your Current Medications Just Not Working? Take Part in an FDA Approved Study for OCD with the latest Deep TMS Technology

About Brainsway Deep TMS

Brainsway* Deep TMS is an innovative, revolutionary technology for the treatment of brain disorders such as OCD. Deep TMS non-invasively stimulates the brain regions responsible for OCD using brief magnetic fields, at an amplitude similar to that used in magnetic resonance imaging (MRI) systems. The device has been cleared by the FDA for treating depression, and has been studied in over 60 clinical trials around the world.  

The treatment does not entail systemic side effects, which are effects deriving from medication entering the bloodstream and circulating throughout the body. 

Brainsway Deep TMS treatment requires only brief daily sessions over a few weeks, without indefinite or permanent medication intake.

About the Study

The study aims to test the efficacy of Deep TMS for OCD patients who have not sufficiently benefitted from their current treatment. The treatment will take place in leading medical centers around the world and is administered by experts. It entails no surgery, hospitalization or medication, and is based on brief daily sessions of 20 minutes over 5 weeks. During the treatment, the patient is comfortably seated in a chair, and a cushioned helmet placed over the head generates brief magnetic fields.

Immediately after each session, patients can drive home independently and resume their daily routine. Patients can continue their current behavioral or medication treatment during the study. The study has been approved by the FDA.

Participant Criteria

Study participants should meet the following criteria: Aged 22-68, diagnosed with OCD with partial or no response to treatment, currently taking SSRI medications or currently undergoing cognitive Behavioral Therapy (CBT), have not had any prior TMS treatment

If you have been diagnosed with OCD, you may be eligible for the study

Study Locations details:

  1. University of Chicago, Chicago, Illinois, USA: Eric Leppink -  773-8343778
  2. Mount Sinai Hospital, New-York, USA: David Rosenthal - 212-659-8803

  3. Spectrum Neuroscience and Treatment Institute, New-York, USA: Eliana Bauman - 646-351-0220
  4. Center for Addiction and Mental Health (CAMH), Toronto, Canada: Mawahib Semeralul - 416-5358501 ext 30210
  5. University of California, Los Angeles, California, USA: Konstantin Kertibiev - 310-206-5133
  6. University of Florida College of Medicine, Florida, USA: Dana Mason - 352-2810032
  7. ​Advanced Mental Health Care Inc. - Juno Beach, Florida, USA: Elyssa Sisko - 561-2678876
  8. Advanced Mental Health Care Inc. - Royal Palm Beach, Florida, USA: Elyssa Sisko - 561-2678876
  9. Tel Hashomer Hospital Ramat Gan, Israel: Tal Weissman - +972-3-5186207

For references click here

© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use